Quick Answer
Pasithea Therapeutics Corp. reported Shares Outstanding of 23.09 million shares for fiscal year 2025.
Pasithea Therapeutics Corp. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 23.09M | +1556.1% |
| 2024 | 1.39M | +33.9% |
| 2023 | 1.04M | -20.0% |
| 2022 | 1.30M | -94.3% |
| 2021 | 23.01M | +208.0% |
| 2020 | 7.47M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 7.44M | +612.4% | +0.0% |
| June 30, 2025 | 7.44M | +612.9% | +175.2% |
| March 31, 2025 | 2.71M | +159.3% | +94.0% |
| December 31, 2024 | 1.39M | +33.9% | +33.4% |
| September 30, 2024 | 1.04M | -95.0% | +0.1% |
| June 30, 2024 | 1.04M | -96.0% | +0.1% |
| March 31, 2024 | 1.04M | -96.0% | +0.2% |
| December 31, 2023 | 1.04M | -96.0% | -95.0% |
- Pasithea Therapeutics Corp. showed an increase of +1556.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Pasithea Therapeutics Corp.’s shares outstanding has grown by 209.2% (from 7.47 million shares to 23.09 million shares).
- The most recent figure is from Pasithea Therapeutics Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: